"北京时间10月1日17时30分许，瑞典卡罗琳斯卡医学院在斯德哥尔摩宣布，将2018年诺贝尔生理学或医学奖授予美国的詹姆斯•艾利森（James Allison）与日本的本庶佑（Tasuku Honjo） ，以表彰他们“发现负性免疫调节治疗癌症的疗法方面的贡献”。 6park.com
他们将获得金质奖章、证书，并分享900万瑞典克朗（约合人民币696万元）的奖金。 6park.com
James Allison和Tasuku Honjo对于癌症免疫疗法的贡献很大， Allison直接提出理论与学说，并且首先应用抗体封闭T细胞信号通路治疗癌症，而Honjo歪打正着最早发现了长期不受重视的PD-1。" 6park.com
"A Japanese molecular immunologist is sharing this year's Nobel Prize in Physiology or Medicine. Tasuku Honjo and an American scientist have been honored for the discovery of cancer therapy by inhibition of negative immune regulation. 6park.com
 6park.com
Honjo's research focuses on antibodies and immune responses. His findings made a significant contribution in explaining how antibodies respond to various viruses and bacteria. 6park.com
The American James Allison studied a protein that functions as a brake on the immune system. He found that by releasing the brake, immune cells could be unleashed to attack tumors. He developed this idea into a new cancer treatment. 6park.com
Honjo graduated from Kyoto University before moving to the United States in 1971 for research. He returned to Kyoto University in 1982 as a professor. He is now a distinguished professor at the university's Institute for Advanced Study. 6park.com
Honjo is the 26th Nobel Prize winner born in Japan. 6park.com
And he's the 5th in the category of Physiology or Medicine, following Yoshinori Ohsumi in 2016."